Pressure injuries (PIs), also known as pressure ulcers or decubitus ulcers, are a significant source of morbidity among intensive care unit (ICU) patients. Optimizing the local microenvironment at the wound site has emerged as a critical component of evidence-based PI management. This review synthesizes current literature on the clinical burden, pathophysiology, and microenvironmental optimization strategies for PIs in critically ill patients. Mechanisms including moisture balance, temperature regulation, pH modulation, oxygenation, and microbial control are discussed alongside risk factors, diagnostic approaches, and cutting-edge interventions. The article concludes with practical guideline recommendations to assist ICU clinicians in the prevention and management of pressure injuries by targeting the wound microenvironment.
Pressure injuries remain a challenging and prevalent complication within the ICU population, with multifactorial etiologies and complex management requirements. Critically ill patients are particularly susceptible due to immobility, critical illness-related catabolism, and the presence of multiple comorbidities. Recent understanding emphasizes not only systemic and mechanical factors but also the microenvironment of the wound site as a pivotal determinant in healing outcomes. This review aims to provide clinicians with a comprehensive overview of the latest research, mechanisms, and practical strategies for optimizing the microenvironment in pressure injury management for ICU patients.
The incidence of pressure injuries in the ICU ranges from 10% to 25%, with higher rates observed in patients with prolonged stays or those requiring mechanical ventilation. PIs are associated with increased morbidity, prolonged hospitalization, higher healthcare costs, and greater risk of secondary infections and mortality. The economic burden is substantial, with treatment costs rising exponentially with PI severity. ICU patients are uniquely vulnerable owing to hemodynamic instability, sedation, and limited mobility, underlining the need for robust preventive and therapeutic measures.
Pressure injuries develop due to sustained tissue compression, leading to localized ischemia, hypoxia, and subsequent tissue necrosis. The microenvironment of the wound encompassing moisture, temperature, pH, oxygenation, and microbial flora plays a crucial role in either facilitating healing or perpetuating injury. Imbalances such as excessive moisture, elevated wound temperature, acidic or alkaline pH, and poor oxygenation can impair cellular processes, disrupt the extracellular matrix, and favor pathogenic colonization, ultimately delaying or preventing wound healing.
Key risk factors for PI development in ICU patients include immobility, poor nutritional status, advanced age, incontinence, vasopressor use, hypoalbuminemia, and underlying comorbidities such as diabetes or vascular disease. Additional factors like impaired sensory perception, sedation, mechanical ventilation, and the presence of medical devices further increase susceptibility. Recognizing these risk factors aids in individualizing preventive strategies and optimizing wound care interventions.
Pressure injuries are classified by the depth and extent of tissue involvement, ranging from non-blanchable erythema (Stage I) to full-thickness tissue loss with exposed muscle, tendon, or bone (Stage IV). Early features include localized erythema, edema, warmth, and tenderness, progressing to ulceration, necrosis, and potential infection. Accurate staging and timely recognition are critical, as early intervention improves outcomes and prevents complications such as osteomyelitis, sepsis, and chronic non-healing wounds.
Diagnosis relies on clinical examination, thorough patient history, and risk assessment tools such as the Braden or Norton scales. Adjunctive assessments may include wound swabbing for microbiological analysis, tissue oxygenation measurement (transcutaneous oximetry), and imaging (ultrasound, MRI) in cases of suspected deep tissue involvement or osteomyelitis. Regular wound surveillance is essential to monitor progression, guide therapy, and detect complications early.
Optimal management of pressure injuries involves a multifaceted approach focusing on pressure offloading, nutritional support, and microenvironmental optimization. Advanced wound dressings that maintain moisture balance, regulate pH, and provide a barrier to pathogens are integral. Negative pressure wound therapy (NPWT), hydrocolloid and foam dressings, and antimicrobial-impregnated materials may be employed based on wound characteristics. Systemic factors such as glycemic control, protein supplementation, and correction of anemia further support tissue repair. Multidisciplinary collaboration among intensivists, wound care specialists, nurses, and dietitians is critical in optimizing outcomes.
Recent advances in PI management emphasize novel dressings with enhanced microenvironmental control, such as those incorporating silver nanoparticles, honey, or growth factors. Oxygen- and pH-modulating dressings, as well as smart dressings capable of real-time wound monitoring, represent promising developments. The use of NPWT with instillation, bioengineered skin substitutes, and topical stem cell therapies are being explored in clinical studies. Preliminary evidence suggests that these technologies may improve healing rates, reduce infection, and minimize scarring, although further research is needed for routine adoption.
International guidelines, including those from the National Pressure Injury Advisory Panel (NPIAP) and the European Pressure Ulcer Advisory Panel (EPUAP), underscore the importance of individualized risk assessment, pressure redistribution, and microenvironment-focused wound care. Key recommendations include routine repositioning, use of support surfaces, maintaining moisture balance, frequent wound assessment, and early intervention at the first signs of PI. Adherence to these guidelines, in conjunction with emerging evidence-based therapies, is crucial for optimizing outcomes in ICU patients.
Pressure injury management in ICU patients necessitates a comprehensive approach that integrates systemic care with targeted microenvironmental optimization. Understanding the underlying pathophysiology, adopting advanced wound technologies, and adhering to guideline-based practices are fundamental to reducing the burden of PIs in critically ill populations. Ongoing research and innovation in this field hold promise for further improving healing rates and patient outcomes.
1.
Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'
2.
For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.
3.
Formaldehyde releasers found in common personal care products used especially by Black and Latina women
4.
AI catches one-third of interval breast cancers missed at screening
5.
For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.
1.
A Closer Look at the Effects of Sickle Cell on Eyesight
2.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
3.
Ferroptosis-Modulating Therapeutics in Precision Oncology
4.
Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management
5.
Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XVI
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation